Immunoglobulin Metabolism in Ataxia Telangiectasia
Overview
Affiliations
Immunoglobulin metabolism has been studied in five patients with ataxia telangiectasia and in control subjects. Serum IgG levels were normal, increased, or decreased, reflecting normal, increased, or decreased synthetic rates, respectively. Serum IgM concentration was normal in three cases and slightly elevated in two cases. IgM turnover studies in the three cases with normal serum IgM levels showed normal IgM synthetic and catabolic rates. None of the five patients with ataxia telangiectasia had detectable serum IgA, and the maximum IgA synthetic rates possible for these patients were 0.3-10% of the normal mean synthetic rate (24 +/- 15 mg/kg per day) of 12 control individuals. Three of the patients had normal IgA fractional catabolic rates: 22% of the intravascular pool per day vs. 25 +/- 4% in controls. In two patients, fractional catabolic rates 4 and 20 times normal were found. In these cases, metabolic turnover, in vitro precipitation, radioimmunoelectrophoresis, and (or) the C'la fixation and transfer test provided evidence for the presence of a circulating antibody directed against IgA causing immune elimination of the molecule. These studies suggest that therapy with exogenous IgA may not be possible in some patients with ataxia telangiectasia or in other subjects with dysgammaglobulinemia.
The natural history of ataxia-telangiectasia (A-T): A systematic review.
Petley E, Yule A, Alexander S, Ojha S, Whitehouse W PLoS One. 2022; 17(3):e0264177.
PMID: 35290391 PMC: 9049793. DOI: 10.1371/journal.pone.0264177.
IgA: Structure, Function, and Developability.
de Sousa-Pereira P, Woof J Antibodies (Basel). 2019; 8(4).
PMID: 31817406 PMC: 6963396. DOI: 10.3390/antib8040057.
Molecular nature of radiation injury and DNA repair disorders associated with radiosensitivity.
Masuda Y, Kamiya K Int J Hematol. 2012; 95(3):239-45.
PMID: 22351161 DOI: 10.1007/s12185-012-1008-y.
Waldmann T, Broder S, Goldman C, Frost K, Korsmeyer S, Medici M J Clin Invest. 1983; 71(2):282-95.
PMID: 6822665 PMC: 436866. DOI: 10.1172/jci110768.
Delacroix D, Elkom K, Geubel A, Hodgson H, Dive C, Vaerman J J Clin Invest. 1983; 71(2):358-67.
PMID: 6401770 PMC: 436875. DOI: 10.1172/jci110777.